Table 2.
Unadjusted perioperative and histopathologic outcomes among patients who received neoadjuvant chemotherapy and chemoradiation followed by surgical resection for gastric cancer.
| Unmatched | Matched | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Chemotherapy, N (%) | Chemoradiation, N (%) | p-value | Chemotherapy, N (%) | Chemoradiation, N (%) | p-value | |
|
|
||||||
| Perioperative Outcomes | ||||||
| 30-day Readmission | 222 (5.3) | 387 (6.9) | 0.001 | 168 (5.7) | 206 (7.0) | 0.042 |
| 30-day Mortality | 78 (1.9) | 135 (2.4) | 0.06 | 61 (2.1) | 84 (2.9) | 0.053 |
| 90-day Mortality | 183 (4.3) | 321 (5.7) | 0.002 | 142 (4.8) | 172 (5.8) | 0.082 |
| Length of Stay, median [IQR] | 8 [6-11] | 9 [7-13] | <0.001 | 8 [6-11] | 9 [7-13] | <0.001 |
|
| ||||||
| Histopathologic Outcomes | ||||||
| Pathologic Complete Response | 304 (7.2) | 826 (14.7) | <0.001 | 231 (7.9) | 439 (14.9) | <0.001 |
| Negative Margins | 3,841 (91.0) | 5,264 (95.6) | <0.001 | 2,670 (90.6) | 2,832 (96.1) | <0.001 |
| Negative Pathologic Lymph Nodes | 1,928 (45.7) | 3,320 (59.2) | <0.001 | 1,355 (46.0) | 1,759 (59.7) | <0.001 |